GAO Report Requested by Sen. Stabenow, Rep. Maloney Finds Government Provided $162 Million to Fund Development of Remdesivir
April 02, 2021
April 02, 2021
WASHINGTON, April 2 (TNSRes) -- Rep. Carolyn Maloney, D-New York, chair of the House Oversight and Reform Committee, issued the following news release on April 1, 2021:
The U.S. Government Accountability Office (GAO) released a new report reviewing the government funding that led to the development of the drug Remdesivir, which costs $3,120 for a five day course of treatment. The report finds that the Centers for Disease Control and Prevention, the Department of Defense and the Nati . . .
The U.S. Government Accountability Office (GAO) released a new report reviewing the government funding that led to the development of the drug Remdesivir, which costs $3,120 for a five day course of treatment. The report finds that the Centers for Disease Control and Prevention, the Department of Defense and the Nati . . .